Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CFH Protein via Ice Microneedles for Radiation-Induced Skin Fibrosis
NCT07567235Phase 1Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2026
- Primary completion
- Mar 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label trial in radiation-induced skin fibrosis (RISF) (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Dose-Limiting Toxicities at 28 days and Adverse Events at 6 months. Started Jun 2026; status: recruiting.
02
Conditions
radiation-induced skin fibrosis (RISF)
Beyond the preview
Go deeper on NCT07567235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07567235.